Showing 1,881 - 1,900 results of 8,597 for search 'effective dysfunction', query time: 0.17s Refine Results
  1. 1881

    Transplantation of Human Urine-Derived Stem Cells Ameliorates Erectile Function and Cavernosal Endothelial Function by Promoting Autophagy of Corpus Cavernosal Endothelial Cells in... by Chi Zhang, Daosheng Luo, Tingting Li, Qiyun Yang, Yun Xie, Haicheng Chen, Linyan Lv, Jiahui Yao, Cuncan Deng, Xiaoyan Liang, Rongpei Wu, Xiangzhou Sun, Yuanyuan Zhang, Chunhua Deng, Guihua Liu

    Published 2019-01-01
    “…The present study is aimed at determining the contribution of autophagy in cavernosal endothelial dysfunction of DED rats and explaining the therapeutic effect of urine-derived stem cells (USCs). …”
    Get full text
    Article
  2. 1882
  3. 1883

    Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 ameliorate barrier dysfunction in human induced pluripotent stem cell-derived crypt-villus stru... by Kyosuke Kobayashi, Yuri Imai, Yuka Shimizu, Isamu Ogawa, Isamu Ogawa, Takaaki Nakai, Yuri Mizuno, Yoshika Kaneda, Yumiko Watanabe-Yasuoka, Fuka Yamazaki, Junko Mochizuki, Toshihiro Sashihara, Tamihide Matsunaga, Tamihide Matsunaga, Takahiro Iwao, Takahiro Iwao

    Published 2025-06-01
    “…Finally, transcriptome analysis suggested that they ameliorated the aberration in cytokine-induced cell differentiation via an anti-inflammatory effect on intestinal stem cells.ConclusionsThe results indicate that LAB ameliorate the cytokine-induced dysfunction of intestinal barrier integrity and homeostasis disrupted by cytokines in a co-culture model of hiPSC-SI and LAB.…”
    Get full text
    Article
  4. 1884

    Machine learning prediction of metabolic dysfunction-associated fatty liver disease risk in American adults using body composition: explainable analysis based on SHapley Additive e... by Yan Hong, Xinrong Chen, Ling Wang, Fan Zhang, ZiYing Zeng, Weining Xie

    Published 2025-06-01
    “…BackgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent and progressive liver disorder closely linked to obesity and metabolic dysregulation. …”
    Get full text
    Article
  5. 1885

    Epidemiological transition of metabolic dysfunction-associated steatotic liver disease-related chronic liver disease and cirrhosis: a comparative study between China and the global... by Yi Tang, Yi Tang, Changhao Gu, Changhao Gu

    Published 2025-07-01
    “…ObjectivesThis study systematically evaluates the epidemiological transition of metabolic dysfunction-associated steatotic liver disease (MASLD)-related chronic liver diseases (CLD) and cirrhosis burden in China versus global populations (1990–2021), with emphasis on age-sex stratified disparities in incidence, prevalence, mortality, and disability-adjusted life years (DALYs). …”
    Get full text
    Article
  6. 1886
  7. 1887

    The role of plasma glucose in association of food-specific serum immunoglobulin G reactivity with metabolic dysfunction-associated fatty liver disease: a real-world cross-sectional... by Guanchao Sun, Wenjuan Wu, Binbin Su, Ru Zhang, Xiaoyu Dong, Lihui Wang, Shiping Xu, Hui Shi

    Published 2025-06-01
    “…Abstract Background As the immune response product to food antigens, food-specific serum immunoglobulin G reactivity (FSsIgGR) has been reported the clinical relevance to metabolic disorders, but its connections to metabolic dysfunction-associated fatty liver disease (MAFLD) remain underexplored, particularly within Chinese populations. …”
    Get full text
    Article
  8. 1888

    Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver diseas... by Alessandro Colletta, Alessandro Colletta, Katherine M. Cooper, Giuseppe Placentino, Deepika Devuni, Deepika Devuni, Cosimo Colletta

    Published 2025-05-01
    “…PurposeMetabolic dysfunction-associated steatotic liver disease (MASLD) increases the risk of chronic kidney disease (CKD), compounding morbidity in patients with cirrhosis. …”
    Get full text
    Article
  9. 1889

    Carbamazepine in Ventricular Extrasystoles Management: Clinical Case by Leonid S. Gordeev, Ekaterina K. Kulbachinskaya, Vera V. Bereznitskaya

    Published 2023-07-01
    “…The drug’s antiarrhythmic effect was demonstrated previously in a number of experimental and clinical studies. …”
    Get full text
    Article
  10. 1890
  11. 1891
  12. 1892

    Neonicotinoid-Induced Cytotoxicity: Insights into Cellular Mechanisms and Health Risks by Yuqing Ma, Qiangwei Wang

    Published 2025-07-01
    “…The underlying mechanisms involve metabolic disturbances, mitochondrial dysfunction, and oxidative stress. These cellular effects raise serious concerns about the potential risks neonicotinoids pose to both human health and the environment. …”
    Get full text
    Article
  13. 1893

    Study of acute toxicity, endothelial- and cardioprotective properties of phenolic and thiophenolic derivatives of 2H-imidazoles by O. A. Puchenkova, O. V. Shheblykina, D. A. Kostina, A. A. Bolgov, P. R. Lebedev, V. V. Molchanov, T. G. Pokrovskaya, M. V. Korokin, E. A. Nikiforov, N. F. Vaskina, T. A. Idrisov, T. D. Moseev, V. V. Melekhin, M. V. Varaksin, V. N. Charushin, O. N. Chupakhin

    Published 2025-07-01
    “…To assess the endothelial protective effect, the levels of systolic and diastolic blood pressure were evaluated, as well as the coefficient of endothelial dysfunction; for the cardioprotective effect, the results of stress tests on the myocardium were evaluated.Results. …”
    Get full text
    Article
  14. 1894
  15. 1895
  16. 1896

    Nitazoxanide Modulates Mitochondrial Function and Inflammatory Metabolism in Chondrocytes from Patients with Osteoarthritis via AMPK/mTORC1 Signaling by Ha Eun Kim, Jong Yeong Lee, Ga-Yeon Son, Jun-Young Park, Ki Bum Kim, Chul-Min Choi, Young Jae Moon, Jin Kyeong Choi

    Published 2025-04-01
    “…NTZ can, therefore, effectively inhibit inflammatory metabolic reprogramming and mitochondrial dysfunction in OA chondrocytes through AMPK-dependent mTORC1 signaling inhibition, highlighting its potential as a disease-modifying therapy for OA.…”
    Get full text
    Article
  17. 1897

    Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control by Seung Hee Lee, Hyeon Young Park, Ji Ho Yun, Eun Kyoung Do

    Published 2025-07-01
    “…By incorporating recent discoveries, we aim to establish a conceptual basis for future translational research on glucagon’s systemic effects within the framework of diabetic cardiometabolic dysfunction.…”
    Get full text
    Article
  18. 1898

    From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance by Asar TO, Al-hejaili OD, El-Sawy HS, Abd-Allah FI, Omar AM, Ahmed TA, El-Say KM

    Published 2025-04-01
    “…Keywords: erectile dysfunction, avanafil, inclusion complex, sublingual tablets, pharmacokinetic study…”
    Get full text
    Article
  19. 1899

    Efficacy and Safety of Chronic Blepharitis Treatment by S. V. Yanchenko, A. V. Malyshev, Sh. Zh. Teshaev, L. M. Petrosyan, Sh. Sh. Ramazonova

    Published 2023-12-01
    “…Methods: 30 posterior or mixed chronic blepharitis (CB), meibomian gland dysfunctions (MGD) and dry eye (DE) patients were examined. …”
    Get full text
    Article
  20. 1900